Jana Gump
- Co-authors
- Daniel M. SullivanNikola ValkovEdward SetoShih‐Chang TsaiWen‐Ming YangLori HazlehurstPamela N. MünsterChunchun Zhang
- Topics
- Cancer therapeutics and mechanisms (12 papers)DNA and Nucleic Acid Chemistry (2 papers)Cancer Research and Treatments (2 papers)
- Cited by
- OncologyHematologyMolecular Biology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Jana Gump
12 papers receiving 410 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 300
- Oncology 195
- Hematology 55
- Surgery 51
- Cancer Research 33
Countries citing papers authored by Jana Gump
This map shows the geographic impact of Jana Gump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Gump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Gump more than expected).
Fields of papers citing papers by Jana Gump
This network shows the impact of papers produced by Jana Gump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Gump. The network helps show where Jana Gump may publish in the future.
Co-authorship network of co-authors of Jana Gump
This figure shows the co-authorship network connecting the top 25 collaborators of Jana Gump. A scholar is included among the top collaborators of Jana Gump based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Gump. Jana Gump is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | Is cytoplasmic localization of topoisomerase I (topo I) a mechanism of resistance for topo I inhibitors? Results from an NCCN sponsored phase II trial of gemcitabine and irinotecan in metastatic breast cancer. | 1 |
| 3 | Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo | 0 |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 157 | |
| 7 | Nuclear and cytoplasmic topoisomerase II alpha are differentially phosphorylated and nuclear export is blocked by CRM1 antisense oligonucleotides | 1 |
| 8 | 30 | |
| 9 | 133 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 17 | |
| 13 | 14 | |
| 14 | 40 |
About Jana Gump
Jana Gump is a scholar working on Oncology, Biotechnology and Molecular Biology, having authored 14 papers that have together received 419 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), DNA and Nucleic Acid Chemistry (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (195 citations), Hematology (55 citations) and Molecular Biology (300 citations). Jana Gump has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Daniel M. Sullivan, Nikola Valkov, Edward Seto, Shih‐Chang Tsai, Wen‐Ming Yang, Lori Hazlehurst, Pamela N. Münster, Chunchun Zhang, William S. Dalton and James M. Cook. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.